Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.

American heart journal - 1 Dec 2005

Cenarro Ana, Artieda Marta, Gonzalvo Carmen, Meriño-Ibarra Erardo, Arístegui Rosa, Gañán Alberto, Díaz Cristina, Sol Josep María, Pocoví Miguel, Civeira Fernando

Abstract excerpt

BACKGROUND: Combined hyperlipidemia (CHL) is a very frequent dyslipidemia, being lipid-lowering drugs often necessary in its management. Some genetic loci have been associated with CHL, and modulation of lipid-lowering treatment by genetic polymorphisms has been reported. We have investigated whether common polymorphisms in the hepatic lipase gene (LIPC) influence the baseline lipid concentration and the response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atorvastatin
Share to Cytosine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Heptanoic Acids

Share to Hyperlipidemias

Share to Hypolipidemic Agents

Share to Lipase

Share to Pyrroles

Share to Thymine

Source

Identifiers

PMID: 16338252
DOI: 10.1016/j.ahj.2005.02.006

Genes

LIPC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.PMID 16338252Read ↗

Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men.Semantic proximity Read ↗

Combined hyperlipidemia: familial but not (usually) monogenic.Semantic proximity Read ↗

Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia.Semantic proximity Read ↗

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.Semantic proximity Read ↗

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity Read ↗

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined HypocholesterolemiaSemantic proximity Read ↗

Gene-statin interaction study identifies 9 loci that moderate statin effectiveness in blood lipidsSemantic proximity Read ↗

Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.Semantic proximity Read ↗

Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC).Semantic proximity Read ↗

The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis.Semantic proximity Read ↗

Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study.Semantic proximity Read ↗

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.